Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | LPL | P06858 | 13/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | F11 | P03951 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9901342 | 0.89 | LIPG (0.47) | HIF1ALPLLIPGF11ESR2 | |
| SCHEMBL13098391 | 0.86 | HIF1A (0.41) | HIF1ALPLLIPGFFAR1F11 | |
| SCHEMBL429980 | 0.86 | HIF1A (0.41) | HIF1ALPLLIPGFFAR1F11 | |
| SCHEMBL29638828 | 0.82 | LIPG (0.44) | LPLLIPGF11 | |
| SCHEMBL12056854 | 0.82 | LIPG (0.44) | LPLLIPGF11 | |
| SCHEMBL10295966 | 0.82 | LIPG (0.42) | HIF1ALPLLIPGFFAR1DGAT1 | |
| SCHEMBL12865805 | 0.79 | SNCA (0.43) | HIF1ALPLLIPGF11DGAT1 | |
| SCHEMBL13648561 | 0.78 | HIF1A (0.42) | HIF1ALPLLIPGFFAR1F11 | |
| SCHEMBL13308814 | 0.78 | HIF1A (0.34) | HIF1ALPLLIPG | |
| SCHEMBL431831 | 0.78 | LIPG (0.47) | LPLLIPGDGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7883786-B2 | highly efficient and highly luminescent optical power and is superior in durability | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-7883786-B2 | highly efficient and highly luminescent optical power and is superior in durability | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LEF1, CYP1B1, ESR1 | HIF1A 2858/4885LPL 1927/4885LIPG 3067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.